These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30041147)

  • 1. Historical and clinical factors associated with positive urine toxicology screening on labor and delivery.
    Son SL; Guiahi M; Heyborne KD
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():261-266. PubMed ID: 30041147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial differences in indications for obstetrical toxicology testing and relationship of indications to test results.
    Perlman NC; Cantonwine DE; Smith NA
    Am J Obstet Gynecol MFM; 2022 Jan; 4(1):100453. PubMed ID: 34352428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association Between Antenatal Maternal Self-reported Substance Use, Maternal Characteristics, and Obstetrical Variables.
    Berra A; Kamo S; Mohnot S; Rosselot J; Suire A; Stafford J; Hagan J; Stafford I
    J Addict Med; 2019; 13(6):464-469. PubMed ID: 31033670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-wide estimation of illicit drug use in delivering women: prevalence, demographics, and associated risk factors.
    Vaughn AJ; Carzoli RP; Sanchez-Ramos L; Murphy S; Khan N; Chiu T
    Obstet Gynecol; 1993 Jul; 82(1):92-6. PubMed ID: 8515933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of cocaine abuse during pregnancy in Barcelona.
    Martinez Crespo JM; Antolín E; Comas C; Coll O; Marqués JM; Gual A; Fortuny A
    Eur J Obstet Gynecol Reprod Biol; 1994 Sep; 56(3):165-7. PubMed ID: 7821487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric patients in the pediatric emergency department undergoing routine urine toxicology screens for medical clearance: results and use.
    Fortu JM; Kim IK; Cooper A; Condra C; Lorenz DJ; Pierce MC
    Pediatr Emerg Care; 2009 Jun; 25(6):387-92. PubMed ID: 19458561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of substance abuse in patients with suspected preterm labor.
    Ney JA; Dooley SL; Keith LG; Chasnoff IJ; Socol ML
    Am J Obstet Gynecol; 1990 Jun; 162(6):1562-5; discussion 1565-7. PubMed ID: 2360589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of illicit drugs detected in the urine of women of childbearing age in Alabama public health clinics.
    Pegues DA; Engelgau MM; Woernle CH
    Public Health Rep; 1994; 109(4):530-8. PubMed ID: 8041853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Maternal-Fetal Triage Index in a tertiary care labor and delivery unit.
    Kodama S; Mokhtari NB; Iqbal SN; Kawakita T
    Am J Obstet Gynecol MFM; 2021 Jul; 3(4):100351. PubMed ID: 33757932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of questionnaire screening and urine toxicology for detection of pregnancy complicated by substance use.
    Christmas JT; Knisely JS; Dawson KS; Dinsmoor MJ; Weber SE; Schnoll SH
    Obstet Gynecol; 1992 Nov; 80(5):750-4. PubMed ID: 1407909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine Drug Screening for Patients in the Emergency Department of a State Psychiatric Hospital: A Naturalistic Cohort Study.
    Margolis A; Rosca P; Kurs R; Sznitman SR; Grinshpoon A
    J Dual Diagn; 2016; 12(3-4):218-226. PubMed ID: 27779447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
    Melchor JC; Navas H; Marcos M; Iza A; De Diego M; Rando D; Melchor I; Burgos J
    Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Drug Abuse Screening Test (DAST-10): A study on illicit drug use among Chinese pregnant women.
    Lam LP; Leung WC; Ip P; Chow CB; Chan MF; Ng JW; Sing C; Lam YH; Mak WL; Chow KM; Chin RK
    Sci Rep; 2015 Jun; 5():11420. PubMed ID: 26091290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance abuse treatment linked with prenatal visits improves perinatal outcomes: a new standard.
    Goler NC; Armstrong MA; Taillac CJ; Osejo VM
    J Perinatol; 2008 Sep; 28(9):597-603. PubMed ID: 18580882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use in pregnancy.
    Wong S; Ordean A; Kahan M; ; ; ; ;
    J Obstet Gynaecol Can; 2011 Apr; 33(4):367-384. PubMed ID: 21501542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatal illicit drug screening practices in mother-newborn dyads at a university hospital serving rural/semi-urban communities: translation of research to quality improvement.
    Oral R; Koc F; Bayman EO; Assad A; Austin A; Strang T; Bayman L
    J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2441-6. PubMed ID: 22716202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of cocaine use in pregnancy.
    McCalla S; Minkoff HL; Feldman J; Glass L; Valencia G
    Obstet Gynecol; 1992 May; 79(5 ( Pt 1)):641-4. PubMed ID: 1565342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients' characteristics and providers' attitudes: predictors of screening pregnant women for illicit substance use.
    Kerker BD; Horwitz SM; Leventhal JM
    Child Abuse Negl; 2004 Feb; 28(2):209-23. PubMed ID: 15003403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.